ALT vs GL · rev $20.0K vs P/E 10, $10.26B cap
Altimmune Inc (ALT) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
GL does not have a complete income-statement cache yet.
ALT currently screens at market cap $527.0M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the ALT and GL stock pages for the full models.
Not investment advice.